Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 790 | 742 | 930 | 1,072 | 501 |
| Cost of Goods | 336 | 507 | 450 | 419 | 253 |
| Gross Profit | 454 | 235 | 480 | 653 | 248 |
| Operating Expenses | 2,959 | 106 | 3,044 | 6,448 | 3,136 |
| Operating Income | -2,169 | 637 | -2,114 | -5,376 | -2,635 |
| Other Income | 48 | -2,545 | -271 | -128 | 1,874 |
| Pre-tax Income | -2,121 | -1,908 | -2,384 | -5,503 | -761 |
| Net Income Continuous | -2,121 | -1,908 | -2,384 | -5,503 | -761 |
| Net Income | $-2,121 | $-1,908 | $-2,384 | $-5,503 | $-761 |
| EPS Basic Total Ops | -0.55 | -1.70 | -0.91 | -1.42 | -0.44 |
| EPS Basic Continuous Ops | -0.55 | -1.69 | -0.91 | -1.42 | -0.44 |
| EPS Diluted Total Ops | -0.55 | -1.70 | -0.91 | -1.42 | -0.44 |
| EPS Diluted Continuous Ops | -0.55 | -1.69 | -0.91 | -1.42 | -0.44 |
| EBITDA(a) | $-2,075 | $725 | $-2,028 | $-5,290 | $-2,546 |